Products and Services

Clement Clarke has announced the launch of its Clip-Tone technique guidance whistle for use with GSK's Evohaler Ventolin and Seretide MDIs in the UK. The Clip-Tone will be available by prescription only. Like the company's Flo-Tone inhaler training device, the Clip-Tone provides audio feedback when the patient inhales at the correct inhalation rate, with the tone … [Read more...] about Clement Clarke launches Clip-Tone inhaler feedback device

CDMO Particle Sciences is now registered with the US Drug Enforcement Administration (DEA) as a manufacturer of Schedule I substances, which means that the company can now provide development and manufacturing services for pharmaceutical cannabinoid products. The company points out that it has long been developing and manufacturing Schedule II-V drugs, including … [Read more...] about Particle Sciences gets authorization for manufacturing of Schedule I drugs

Proveris Scientific has announced the availability of new testing services that "support the FDA’s newly released draft guidance on beclomethasone dipropionate that promotes alternate in-vitro studies in lieu of clinical endpoint." According to Proveris, the new services are "Based on an innovative new proprietary technology" and "have been developed in … [Read more...] about Proveris Scientific adds new IVIVC testing services

Inhalation Sciences (ISAB) has announced that it will divest 40,000 shares of its subsidiary Ziccum AB in order to finance a study to validate its PreciseInhale dosing system for clinical use. The company said that it anticipates achieving technical and regulatory validation in approximately 15 months. PreciseInhale, which can produce aerosols at a specified dose … [Read more...] about Inhalation Sciences announces plans to validate its PreciseInhale instrument for clinical use

KAER Biotherapeutics has received a $300,000 Small Business Innovation Research (SBIR) grant from the National Heart Lung and Blood Institute of the National Institutes of Health for preclinical development of its SUPRAER aerosol platform for the treatment of surfactant-deficient premature infants with Respiratory Distress Syndrome (nRDS), the company said. The … [Read more...] about KAER Biotherapeutics gets SBIR grant for development of aerosol therapy for RDS in premature infants

Aptar Pharma has announced that GSK's Otrivin xylometazoline nasal spray, which is delivered via Aptar's Freepod multidose nasal spray pump, won a 2019 WorldStar Packaging Award in the Medical & Pharma category. The WorldStar Packaging Awards, given by the World Packaging Organization, "are based on the judges' consensus that a pack is superior in its category and … [Read more...] about GSK’s Otrivin + Aptar Pharma’s Freepod nasal pump wins WorldStar Packaging Award

Lonza has announced the launch of a new DPI capsule portfolio called Capsugel Zephyr "to meet the growing need for customized solutions for optimal pulmonary drug delivery." The new DPI capsules are customizable and can be made from a variety of "different polymers and compositions," with "product customization services to help address the specific needs of inhalation … [Read more...] about Lonza launches Capsugel Zephyr DPI capsules

Recipharm has announced the launch of an integrated OINDP services program called Inhalation Solutions which covers development of MDIs, DPIs, and nasal sprays from early analytical services to scale up and commercial manufacturing. In June 2018, Recipharm acquired an inhalation manufacturing business in Holmes Chapel, UK from Sanofi. The company also has had … [Read more...] about Recipharm launches integrated inhalation services

Intertek has acquired a a new 20,000 sq. ft facility in Melbourn, UK, doubling the size of its existing laboratory facilities at that location, the company said. As part of the expansion, Intertek said, the company plans to hire approximately 100 new employees over 4 years. The new facility, which should open by the end of the year, will have additional space for … [Read more...] about Intertek Melbourn opens new facility for inhaled drug and biologic development